Related Experiment Videos
Irreversible renal failure after intraperitoneal cisplatin administration. A case report
S F Gouge1, D P Tietjen, J Moore
1Department of Medicine, Walter Reed Army Medical Center, Washington, D.C. 20307-5001.
The Journal of Reproductive Medicine
|November 1, 1989
Summary
Intraperitoneal cisplatin can cause permanent kidney damage, even after one dose. Pre-existing kidney issues and dehydration increase the risk of this severe nephrotoxicity.
Area of Science:
- Oncology
- Nephrology
- Pharmacology
Background:
- Intraperitoneal cisplatin is utilized for localized tumor control, aiming for high drug concentrations within the peritoneal cavity while minimizing systemic exposure and toxicity.
- This administration route is intended to enhance therapeutic efficacy in specific cancer types.
Observation:
- A case report details a patient who experienced irreversible renal failure after receiving a single dose of intraperitoneal cisplatin.
- The patient had a history of mild renal insufficiency potentially linked to previous intravenous cisplatin treatment.
Findings:
- Severe vomiting led to volume depletion and inadequate diuresis, exacerbating cisplatin-induced nephrotoxicity.
- Despite high intraperitoneal drug levels, concurrent serum concentrations comparable to intravenous administration likely contributed to the observed permanent kidney damage.
Implications:
- This case highlights the potential for severe nephrotoxicity from intraperitoneal cisplatin, even with single-dose administration.
- Careful patient selection and vigilant monitoring of renal function and hydration status are crucial when using intraperitoneal cisplatin.
- Further research into risk factors and management strategies for intraperitoneal cisplatin-induced nephrotoxicity is warranted.